Application

17788127 · SUBSTITUTED N-(4-(PYRIMIDIN AND PYRIDIN-4-YL)BENZYLCARBOXAMIDES AND ITS USE FOR TREATING DISORDERS RESPONSIVE TO INHIBITION OF BTK

Filed 2022-06-22 · Granted · Patent 12570631 (2026-03-10) The official file ↗The patent and its PDF ↗ · Art unit 1627 · Examiner Sophia Jane Reilly Easy · CPC C07D 401/14 · BIOGEN MA INC. · McCarter & English, LLP / Biogen MA

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

35.4 mo

to disposition 44.6 mo

Statutes raised

103

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.